Industry stakeholders should still be cautious in creating or revising marketing arrangements given the scope of the AKS, other appellate court decisions in similar cases, and civil enforcement ...

Akston Biosciences Corporation and Biolexis, a Strides Group Company, today announced results from a Phase II/III clinical trial in India of the SARS-CoV-2 vaccine, AKS-452, in which 1,600 healthy ...